| | | | | Product | Package Size | EFP | CP | SB | DC | Composition | Registr. Holder | Category | | | | |
---|
|
|
| | IP | CI | | Metrissa 2 mg | 28 | 39.48 | 59.45 | 10 % | | Coated tablets: Dienogestum 2 mg | Gynial AG | B / SL / SG | FB | | G |  |
| | IP | CI | | Metrissa 2 mg | 3 x 28 | 100.67 | 126.20 | 10 % | | Coated tablets: Dienogestum 2 mg | Gynial AG | B / SL / SG | FB | | G |  |
| | IP | CI | | Brimo-Vision 2 mg/ml | 60 x 0.35 ml | 8.52 | 25.70 | 10 % | | Augentropfen (Einzeldosen): Brimonidini Tartras 2 mg/ml | OmniVision AG | B / SL / SG | FB | | G |  |
| | IP | CI | | Brimo-Vision 2 mg/ml | 180 x 0.35 ml | 19.94 | 38.10 | 10 % | | Augentropfen (Einzeldosen): Brimonidini Tartras 2 mg/ml | OmniVision AG | B / SL / SG | FB | | G |  |
L | | IP | | | Bortezomib Accord 1 mg | | 126.04 | 153.50 | 10 % | | Pulver zur Herstellung einer lnjektionslösung: Bortezomibum 1 mg | Accord Healthcare AG | A / SL / SG | FB | | G |  |
L | | IP | | | Bortezomib Accord 3.5 mg | | 372.78 | 421.85 | 10 % | | Pulver zur Herstellung einer lnjektionslösung: Bortezomibum 3.5 mg | Accord Healthcare AG | A / SL / SG | FB | | G |  |
L | | IP | CI | | Idacio 40 mg/ 0.8 ml | 2 | 742.19 | 823.50 | 10 % | | Injection solution in prefilled syringe: Adalimumabum 40mg / 0.8ml | Fresenius Kabi (Schweiz) AG | B / SL | FB | | G |  |
L | | IP | | | Sarclisa 100 mg/5 mL | | 504.35 | 564.95 | 10 % | | Concentrate for infusion: Isatuximabum 100mg / 5ml | Sanofi-Aventis (Suisse) SA | A / SL | FB | | G |  |
L | | IP | | | Sarclisa 500 mg/25 mL | | 2521.75 | 2758.95 | 10 % | | Concentrate for infusion: Isatuximabum 500mg / 25ml | Sanofi-Aventis (Suisse) SA | A / SL | FB | | G |  |
L | | IP | CI | | Piqray 150 mg | 28 | 1483.58 | 1629.90 | 10 % | | Coated tablets: Alpelisibum 150 mg | Novartis Pharma Schweiz AG | A / SL | FB | | G |  |
L | | IP | CI | | Piqray 150 mg | 56 | 2982.21 | 3259.75 | 10 % | | Coated tablets: Alpelisibum 150 mg | Novartis Pharma Schweiz AG | A / SL | FB | | G |  |
L | | IP | | | Piqray 200 mg | 28 | 2982.21 | 3259.75 | 10 % | | Coated tablets: Alpelisibum 200 mg | Novartis Pharma Schweiz AG | A / SL | FB | | G |  |
L | | IP | | | Piqray 200 mg + 50 mg | 14 | 1483.58 | 1629.90 | 10 % | | Coated tablets: Alpelisibum 200 mg Coated tablets: Alpelisibum 50 mg | Novartis Pharma Schweiz AG | A / SL | FB | | G |  |
L | | IP | | | Piqray 200 mg + 50 mg | 28 | 2982.21 | 3259.75 | 10 % | | Coated tablets: Alpelisibum 200 mg Coated tablets: Alpelisibum 50 mg | Novartis Pharma Schweiz AG | A / SL | FB | | G |  |
L | | IP | CI | | Zykadia | 84 | 4003.77 | 4370.75 | 10 % | | Coated tablets: Ceritinibum 150 mg | Novartis Pharma Schweiz AG | A / SL | FB | | G |  |
L | | IP | CI | | Rybelsus 3 mg | 30 | 101.42 | 126.70 | 10 % | | Tablets: Semaglutidum 3 mg | Novo Nordisk Pharma AG | B / SL | FB | | G |  |
L | | IP | | | Rybelsus 7 mg | 30 | 101.42 | 126.70 | 10 % | | Tablets: Semaglutidum 7 mg | Novo Nordisk Pharma AG | B / SL | FB | | G |  |
L | | IP | | | Rybelsus 7 mg | 90 | 304.25 | 347.30 | 10 % | | Tablets: Semaglutidum 7 mg | Novo Nordisk Pharma AG | B / SL | FB | | G |  |
L | | IP | | | Rybelsus 14 mg | 30 | 101.42 | 126.70 | 10 % | | Tablets: Semaglutidum 14 mg | Novo Nordisk Pharma AG | B / SL | FB | | G |  |
L | | IP | | | Rybelsus 14 mg | 90 | 304.25 | 347.30 | 10 % | | Tablets: Semaglutidum 14 mg | Novo Nordisk Pharma AG | B / SL | FB | | G |  |
L | | IP | CI | | Vyndaqel 61 mg | 30 | 9422.28 | 9975.05 | 10 % | | Soft capsules: Tafamidisum 61 mg | Pfizer AG | B / SL | FB | | G |  |
L | | IP | CI | | Viferol D3 25'000 UI/ml | 4 | 5.59 | 15.30 | 10 % | | Solution (oral): Cholecalciferolum 25000 UI/ml | OM Pharma Suisse SA | B / SL | FB | | G |  |
L | | IP | CI | | Idacio 40 mg/0.8 ml | 2 | 742.19 | 823.50 | 10 % | | Injektionslösung im Fertigpen: Adalimumabum 40mg / 0.8ml | Fresenius Kabi (Schweiz) AG | B / SL | FB | | G |  |
| | IP | CI | | Idacio 40 mg/ 0.8 ml | 6 | PR | PR | k.A. | | Injection solution in prefilled syringe: Adalimumabum 40mg / 0.8ml | Fresenius Kabi (Schweiz) AG | B | FB | | G |  |
| | IP | | | Sarclisa 100 mg/5 mL | 3 | PR | PR | k.A. | | Concentrate for infusion: Isatuximabum 100mg / 5ml | Sanofi-Aventis (Suisse) SA | A | FB | | G |  |
| | IP | CI | | Metrissa 2 mg | 6 x 28 | PR | PR | k.A. | | Coated tablets: Dienogestum 2 mg | Gynial AG | B | FB | | G |  |
| | IP | CI | | Nerlynx 40 mg | 180 | PR | PR | k.A. | | Coated tablets: Neratinibum 40 mg | Pierre Fabre Pharma SA | A | FB | | G |  |
| | IP | | | Piqray 200 mg | 14 | PR | PR | k.A. | | Coated tablets: Alpelisibum 200 mg | Novartis Pharma Schweiz AG | A | FB | | G |  |
| | IP | CI | | Vyndaqel 20 mg | 30 | PR | PR | k.A. | | Soft capsules: Tafamidisum Megluminum 20 mg | Pfizer AG | B | FB | | G |  |
| | IP | CI | | Verkazia | 120 x 0.3 ml | PR | PR | k.A. | | Augentropfen Emulsion: Ciclosporinum 1 mg/ml | Santen SA | B | FB | | G |  |
| | IP | CI | | Idacio 40 mg/0.8 ml | 6 | PR | PR | k.A. | | Injektionslösung im Fertigpen: Adalimumabum 40mg / 0.8ml | Fresenius Kabi (Schweiz) AG | B | FB | | G |  |
| | IP | CI | | neotylol Grippe | 12 | PR | PR | k.A. | | Pulver zur Herstellung einer Lösung zum Einnehmen: 4 Active Agents | NOBEL Pharma Schweiz AG | D | FB | | G |  |